← Back to patent-cliff list
Varenicline Oxalate
Tier C — Watch / tradeVarenicline Oxalate
Korea University
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Nicotinic acetylcholine receptor alpha-4/beta-2
Indications (approved)：大麻使用, Cannabis dependence, Nicotine dependence, Nicotine withdrawal, HIV infection, Smoking cessation, 吸烟草, 吸纸烟
Regional status
US
Phase III
2025-05-06
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Varenicline Oxalate?
Approved indications include: 大麻使用, Cannabis dependence, Nicotine dependence, Nicotine withdrawal, HIV infection, Smoking cessation, 吸烟草, 吸纸烟.
When does the Varenicline Oxalate patent expire?
No public expiry year is available for Varenicline Oxalate yet; this page updates once verified.
How do I get a quote for Varenicline Oxalate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02